Researchers from Boston University School of Medicine (BUSM) have found that patients with node-negative T3 and T4 lung non-small suffered chemotherapy before surgery had more than three times of the survival of patients who underwent the surgery only. These results are currently on-line in the journal of thoracic and cardiovascular surgery.
Showing posts with label survival. Show all posts
Showing posts with label survival. Show all posts
Wednesday, April 13, 2011
Tuesday, April 12, 2011
Study links vitamin d for lung cancer Cancer Survival
1
March 2011, ANN ARBOR, Mich. — recent research suggests that vitamin d may be able to stop or prevent cancer. A new study finds an enzyme that plays a role in metabolizing d-vitamin may predict lung cancer survival. This study by researchers at the University of Michigan Comprehensive Cancer Center, now proposes that this enzyme becomes mild effects of vitamin D levels of this enzyme, known as CYP24A1, was high and 50 times in lung adenocarcinoma cancer compared with the normal lung tissue. The highest level of CYP24A1 tumors was likely to be aggressive. Approximately one third of patients with lung cancer had high levels of this enzyme. After five years, the patients almost half the rate of survival as patients with low levels of the enzyme researchers then connects this with how CYP24A1 interacts with calcitriol, the active form of vitamin d. calcitriol CYP24A1 raster, which is a normal and essential role when kept in check box. But when I climb of enzyme CYP24A1 beginning to hamper the positive effects of low levels of vitamin d. results of the study in clinical cancer research.
March 2011, ANN ARBOR, Mich. — recent research suggests that vitamin d may be able to stop or prevent cancer. A new study finds an enzyme that plays a role in metabolizing d-vitamin may predict lung cancer survival. This study by researchers at the University of Michigan Comprehensive Cancer Center, now proposes that this enzyme becomes mild effects of vitamin D levels of this enzyme, known as CYP24A1, was high and 50 times in lung adenocarcinoma cancer compared with the normal lung tissue. The highest level of CYP24A1 tumors was likely to be aggressive. Approximately one third of patients with lung cancer had high levels of this enzyme. After five years, the patients almost half the rate of survival as patients with low levels of the enzyme researchers then connects this with how CYP24A1 interacts with calcitriol, the active form of vitamin d. calcitriol CYP24A1 raster, which is a normal and essential role when kept in check box. But when I climb of enzyme CYP24A1 beginning to hamper the positive effects of low levels of vitamin d. results of the study in clinical cancer research.
Tuesday, April 13, 2010
Stereotactic radiation therapy can improve survival with early stage inoperable lung cancer
When lung cancer is caught early, gives surgery possibility of a cure. But not everyone is a candidate for surgery. And for them-regardless of whether they can refrain from treatment or treated with conventional radiation therapy-survival in 3 years, only about 20-35%.
However, a relatively new technique of radiotherapy, Stereotactic body radiation therapy (SBRT), gives hope that people with lung cancer at an early stage, but it doesn't work it can survive much longer than was possible previously.
Posted by samTrackback "planned study looks AT LUNG cancer in OLD NAVY VETERANS cancer is a preventable diseases – why not we prevent it?"I will leave a replyName (required)
Mail (not published) (required)
Site
© Copyright 2009 Bonnie j. Addario Lung Cancer Foundation; all rights reserved.
601 4th Street Suite 215
Subscribe to:
Posts (Atom)
